Enrique Moya

Title: Innovations of Enrique Moya in G-Protein Coupled Receptor Modulation

Introduction

Enrique Moya is an accomplished inventor based in Berkeley, CA. He has made significant contributions to the field of pharmacology, particularly in the modulation of G-protein coupled receptors. His work focuses on developing chemical entities that can effectively influence receptor activities, which are crucial for treating various diseases.

Latest Patents

Enrique Moya holds a patent for "Modulators of G-protein coupled receptors." This patent features chemical entities that modulate the glucagon-like peptide-1 receptor (GLP-1R) and the gastric inhibitory polypeptide receptor (GIPR). These chemical entities are designed to treat diseases where modulation of GLP-1R and GIPR activities is beneficial. The patent outlines methods for enhancing existing levels of receptor activity and includes compositions for using these chemical entities effectively.

Career Highlights

Enrique Moya is currently associated with Carmot Therapeutics, Inc., where he continues to innovate in the field of receptor modulation. His work has the potential to impact the treatment of various conditions by improving the efficacy of existing therapies.

Collaborations

Enrique has collaborated with notable colleagues such as Raymond V. Fucini and Steven Sethofer. These collaborations have further enriched his research and development efforts in the pharmaceutical domain.

Conclusion

Enrique Moya's contributions to the field of G-protein coupled receptor modulation exemplify the importance of innovation in pharmacology. His patent and ongoing work at Carmot Therapeutics, Inc. highlight his commitment to advancing medical treatments.